The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Lutopron     [(9S,14S,17R)-17-ethanoyl- 10,13-dimethyl-3...

Synonyms: Delalutin, Duraluton, Hylutin, Hyroxon, Luteocrin, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Kaprogest

 

Psychiatry related information on Kaprogest

 

High impact information on Kaprogest

 

Chemical compound and disease context of Kaprogest

 

Biological context of Kaprogest

 

Anatomical context of Kaprogest

 

Associations of Kaprogest with other chemical compounds

 

Gene context of Kaprogest

 

Analytical, diagnostic and therapeutic context of Kaprogest

References

  1. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. Johnson, J.W., Austin, K.L., Jones, G.S., Davis, G.H., King, T.M. N. Engl. J. Med. (1975) [Pubmed]
  2. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. Sibai, B., Meis, P.J., Klebanoff, M., Dombrowski, M.P., Weiner, S.J., Moawad, A.H., Northen, A., Iams, J.D., Varner, M.W., Caritis, S.N., O'Sullivan, M.J., Miodovnik, M., Leveno, K.J., Conway, D., Wapner, R.J., Carpenter, M., Mercer, B., Ramin, S.M., Thorp, J.M., Peaceman, A.M., Gabbe, S. Am. J. Obstet. Gynecol. (2005) [Pubmed]
  3. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Bokhman, J.V., Chepick, O.F., Volkova, A.T., Vishnevsky, A.S. Gynecol. Oncol. (1985) [Pubmed]
  4. Treatment of benign prostatic hyperplasia with hydroxyprogesterone-caproate: placebo-controlled study. Meiraz, D., Margolin, Y., Lev-Ran, A., Lazebnik, J. Urology (1977) [Pubmed]
  5. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Sanchez-Ramos, L., Kaunitz, A.M., Delke, I. Obstetrics and gynecology. (2005) [Pubmed]
  6. Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse. Carbone, J.P., Brent, R.L. Am. J. Obstet. Gynecol. (1993) [Pubmed]
  7. Effects of prenatally administered 17 alpha-hydroxyprogesterone caproate on adolescent males. Kester, P.A. Archives of sexual behavior. (1984) [Pubmed]
  8. Detection of 17alpha-hydroxyprogesterone caproate in equine plasma by gas chromatography/tandem mass spectrometry. McKinney, A.R., Suann, C.J., Stenhouse, A.M. Rapid Commun. Mass Spectrom. (2006) [Pubmed]
  9. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Petrini, J.R., Callaghan, W.M., Klebanoff, M., Green, N.S., Lackritz, E.M., Howse, J.L., Schwarz, R.H., Damus, K. Obstetrics and gynecology. (2005) [Pubmed]
  10. Does progesterone treatment influence risk factors for recurrent preterm delivery? Meis, P.J., Klebanoff, M., Dombrowski, M.P., Sibai, B.M., Leindecker, S., Moawad, A.H., Northen, A., Iams, J.D., Varner, M.W., Caritis, S.N., O'Sullivan, M.J., Miodovnik, M., Leveno, K.J., Conway, D., Wapner, R.J., Carpenter, M., Mercer, B., Ramin, S.M., Thorp, J.M., Peaceman, A.M., Gabbe, S. Obstetrics and gynecology. (2005) [Pubmed]
  11. 17 hydroxyprogesterone for the prevention of preterm delivery. Meis, P.J. Obstetrics and gynecology. (2005) [Pubmed]
  12. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Piver, M.S., Barlow, J.J., Lurain, J.R., Blumenson, L.E. Cancer (1980) [Pubmed]
  13. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma. Vosika, G.J., Ryan, M.J., Fortuny, I.A., Meyer, C., Kiang, D.T., Theologides, A., Kennedy, B.J. Med. Pediatr. Oncol. (1978) [Pubmed]
  14. Exploration for drug therapy in endometrial carcinoma. Zhang, X., Cao, B. Chin. Med. J. (1996) [Pubmed]
  15. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor. Bréart, G., Lanfranchi, M., Chavigny, C., Rumeau-Rouquette, C., Sureau, C. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. (1979) [Pubmed]
  16. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial. Reijnders, F.J., Thomas, C.M., Doesburg, W.H., Rolland, R., Eskes, T.K. British journal of obstetrics and gynaecology. (1988) [Pubmed]
  17. A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. Costabile, L., Gerli, S., Manna, C., Rossetti, D., Di Renzo, G.C., Unfer, V. Fertil. Steril. (2001) [Pubmed]
  18. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations. Onsrud, M. Gynecol. Oncol. (1982) [Pubmed]
  19. Gestational exposure to hydroxyprogesterone caproate suppresses reproductive potential in male rats. Pushpalatha, T., Reddy, P.R., Reddy, P.S. Naturwissenschaften (2005) [Pubmed]
  20. Preferential expression of long form prolactin receptor mRNA in the rat brain during the oestrous cycle, pregnancy and lactation: hormones involved in its gene expression. Sugiyama, T., Minoura, H., Kawabe, N., Tanaka, M., Nakashima, K. J. Endocrinol. (1994) [Pubmed]
  21. Effects of neonatal treatment with diethylstilbestrol and 17 alpha-hydroxyprogesterone caproate on in vitro pituitary prolactin secretion. Lopez, J., Ogren, L., Talamantes, F. Life Sci. (1984) [Pubmed]
  22. Effects of sex steroid hormones on corticosteroid-binding globulin gene expression in human endometrial cancer cell line Ishikawa. Misao, R., Nakanishi, Y., Fujimoto, J., Tamaya, T. Ann. Clin. Biochem. (1998) [Pubmed]
  23. 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. Unfer, V., Casini, M.L., Costabile, L., Gerli, S., Baldini, D., Di Renzo, G.C. Reprod. Biomed. Online (2004) [Pubmed]
  24. Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study. Abate, A., Brigandi, A., Abate, F.G., Manti, F., Unfer, V., Perino, M. Gynecol. Obstet. Invest. (1999) [Pubmed]
  25. The use of progestational agents for preterm birth: lessons from a mouse model. Elovitz, M.A., Mrinalini, C. Am. J. Obstet. Gynecol. (2006) [Pubmed]
  26. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Yemini, M., Borenstein, R., Dreazen, E., Apelman, Z., Mogilner, B.M., Kessler, I., Lancet, M. Am. J. Obstet. Gynecol. (1985) [Pubmed]
  27. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Hauth, J.C., Gilstrap, L.C., Brekken, A.L., Hauth, J.M. Am. J. Obstet. Gynecol. (1983) [Pubmed]
  28. Progestogen administration in pregnancy may prevent preterm delivery. Keirse, M.J. British journal of obstetrics and gynaecology. (1990) [Pubmed]
 
WikiGenes - Universities